Decursin and decursinol inhibit VEGF-induced angiogenesis by blocking the activation of extracellular signal-regulated kinase and c-Jun N-terminal kinase

Seung Hwa Son, Mi Jeong Kim, Won Yoon Chung, Ju Ah Son, Yeong Shik Kim, Young Choong Kim, Sam Sik Kang, Sang Kook Lee, Kwang Kyun Park

Research output: Contribution to journalArticle

41 Citations (Scopus)

Abstract

The root of Angelica gigas Nakai contains two major coumarins, which have been previously identified as decursin and decursinol. Decursin has been demonstrated to exhibit potent anti-cancer activity both in vitro and in vivo. In this study, we found that decursin and decursinol at non-cytotoxic doses inhibited the VEGF-induced proliferation, migration, and capillary-tube formation of HUVECs. Moreover, decursin and decursinol suppressed microvessel formation on chorioallantoic membranes in fertilized eggs and into mouse Matrigel plugs. The oral administration of decursin and decursinol also reduced VEGF-induced angiogenesis in Matrigel. Furthermore, decursin and decursinol reduced the phosphorylation of ERK and JNK, but not p38 MAPK, in VEGF-stimulated HUVECs. Taken together, our results reveal that decursin and decursinol inhibit VEGF-induced angiogenesis by reducing the activation of ERK and JNK in HUVECs, and possess potent in vivo anti-angiogenic activity, coupled with the advantage of oral dosing. Thus, these compounds may have the potential for the treatment of cancers dependent on VEGF-induced vascularization.

Original languageEnglish
Pages (from-to)86-92
Number of pages7
JournalCancer Letters
Volume280
Issue number1
DOIs
Publication statusPublished - 2009 Jul 18

Fingerprint

JNK Mitogen-Activated Protein Kinases
Extracellular Signal-Regulated MAP Kinases
Vascular Endothelial Growth Factor A
decursin
Angelica
Chorioallantoic Membrane
Coumarins
Zygote
p38 Mitogen-Activated Protein Kinases
Microvessels
Oral Administration
Neoplasms

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Cite this

Son, Seung Hwa ; Kim, Mi Jeong ; Chung, Won Yoon ; Son, Ju Ah ; Kim, Yeong Shik ; Kim, Young Choong ; Kang, Sam Sik ; Lee, Sang Kook ; Park, Kwang Kyun. / Decursin and decursinol inhibit VEGF-induced angiogenesis by blocking the activation of extracellular signal-regulated kinase and c-Jun N-terminal kinase. In: Cancer Letters. 2009 ; Vol. 280, No. 1. pp. 86-92.
@article{24c1ffabf2844f9fa039c18d9bd2be1e,
title = "Decursin and decursinol inhibit VEGF-induced angiogenesis by blocking the activation of extracellular signal-regulated kinase and c-Jun N-terminal kinase",
abstract = "The root of Angelica gigas Nakai contains two major coumarins, which have been previously identified as decursin and decursinol. Decursin has been demonstrated to exhibit potent anti-cancer activity both in vitro and in vivo. In this study, we found that decursin and decursinol at non-cytotoxic doses inhibited the VEGF-induced proliferation, migration, and capillary-tube formation of HUVECs. Moreover, decursin and decursinol suppressed microvessel formation on chorioallantoic membranes in fertilized eggs and into mouse Matrigel plugs. The oral administration of decursin and decursinol also reduced VEGF-induced angiogenesis in Matrigel. Furthermore, decursin and decursinol reduced the phosphorylation of ERK and JNK, but not p38 MAPK, in VEGF-stimulated HUVECs. Taken together, our results reveal that decursin and decursinol inhibit VEGF-induced angiogenesis by reducing the activation of ERK and JNK in HUVECs, and possess potent in vivo anti-angiogenic activity, coupled with the advantage of oral dosing. Thus, these compounds may have the potential for the treatment of cancers dependent on VEGF-induced vascularization.",
author = "Son, {Seung Hwa} and Kim, {Mi Jeong} and Chung, {Won Yoon} and Son, {Ju Ah} and Kim, {Yeong Shik} and Kim, {Young Choong} and Kang, {Sam Sik} and Lee, {Sang Kook} and Park, {Kwang Kyun}",
year = "2009",
month = "7",
day = "18",
doi = "10.1016/j.canlet.2009.02.012",
language = "English",
volume = "280",
pages = "86--92",
journal = "Cancer Letters",
issn = "0304-3835",
publisher = "Elsevier Ireland Ltd",
number = "1",

}

Decursin and decursinol inhibit VEGF-induced angiogenesis by blocking the activation of extracellular signal-regulated kinase and c-Jun N-terminal kinase. / Son, Seung Hwa; Kim, Mi Jeong; Chung, Won Yoon; Son, Ju Ah; Kim, Yeong Shik; Kim, Young Choong; Kang, Sam Sik; Lee, Sang Kook; Park, Kwang Kyun.

In: Cancer Letters, Vol. 280, No. 1, 18.07.2009, p. 86-92.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Decursin and decursinol inhibit VEGF-induced angiogenesis by blocking the activation of extracellular signal-regulated kinase and c-Jun N-terminal kinase

AU - Son, Seung Hwa

AU - Kim, Mi Jeong

AU - Chung, Won Yoon

AU - Son, Ju Ah

AU - Kim, Yeong Shik

AU - Kim, Young Choong

AU - Kang, Sam Sik

AU - Lee, Sang Kook

AU - Park, Kwang Kyun

PY - 2009/7/18

Y1 - 2009/7/18

N2 - The root of Angelica gigas Nakai contains two major coumarins, which have been previously identified as decursin and decursinol. Decursin has been demonstrated to exhibit potent anti-cancer activity both in vitro and in vivo. In this study, we found that decursin and decursinol at non-cytotoxic doses inhibited the VEGF-induced proliferation, migration, and capillary-tube formation of HUVECs. Moreover, decursin and decursinol suppressed microvessel formation on chorioallantoic membranes in fertilized eggs and into mouse Matrigel plugs. The oral administration of decursin and decursinol also reduced VEGF-induced angiogenesis in Matrigel. Furthermore, decursin and decursinol reduced the phosphorylation of ERK and JNK, but not p38 MAPK, in VEGF-stimulated HUVECs. Taken together, our results reveal that decursin and decursinol inhibit VEGF-induced angiogenesis by reducing the activation of ERK and JNK in HUVECs, and possess potent in vivo anti-angiogenic activity, coupled with the advantage of oral dosing. Thus, these compounds may have the potential for the treatment of cancers dependent on VEGF-induced vascularization.

AB - The root of Angelica gigas Nakai contains two major coumarins, which have been previously identified as decursin and decursinol. Decursin has been demonstrated to exhibit potent anti-cancer activity both in vitro and in vivo. In this study, we found that decursin and decursinol at non-cytotoxic doses inhibited the VEGF-induced proliferation, migration, and capillary-tube formation of HUVECs. Moreover, decursin and decursinol suppressed microvessel formation on chorioallantoic membranes in fertilized eggs and into mouse Matrigel plugs. The oral administration of decursin and decursinol also reduced VEGF-induced angiogenesis in Matrigel. Furthermore, decursin and decursinol reduced the phosphorylation of ERK and JNK, but not p38 MAPK, in VEGF-stimulated HUVECs. Taken together, our results reveal that decursin and decursinol inhibit VEGF-induced angiogenesis by reducing the activation of ERK and JNK in HUVECs, and possess potent in vivo anti-angiogenic activity, coupled with the advantage of oral dosing. Thus, these compounds may have the potential for the treatment of cancers dependent on VEGF-induced vascularization.

UR - http://www.scopus.com/inward/record.url?scp=67349245011&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67349245011&partnerID=8YFLogxK

U2 - 10.1016/j.canlet.2009.02.012

DO - 10.1016/j.canlet.2009.02.012

M3 - Article

C2 - 19307054

AN - SCOPUS:67349245011

VL - 280

SP - 86

EP - 92

JO - Cancer Letters

JF - Cancer Letters

SN - 0304-3835

IS - 1

ER -